Skip to main content

BioVenture — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

274
Companies
$1.0B
Total invested
$20.1M
Avg. check
26
Industries
Medical 12Biotechnology 11Health Care 11Biopharma 6Therapeutics 5Manufacturing 4+20 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145168 of 274
Apeximmune Therapeutics
March 2025

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

Biotechnology · Burlingame$21.3M Series A
Cellbri
March 2025

Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs.

Machinery Manufacturing · ShanzhenSeries B
Myrobalan Therapeutics
March 2025

Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.

Biotechnology · Medford$850K Grant
MyoGene Life Sciences
January 2025

MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its repair material products for bone repair.

Advanced Materials · ShenzhenSeries A
AnaCardio
January 2025

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Biopharma · Solna$18.4M Series A
Alebund Pharmaceuticals
January 2025

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

Biotechnology · Shanghai$75.1M Series C
Francis Medical
January 2025

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical · Maple Grove$80.0M Series C
Reforgene Medicine
December 2024

Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.

Biotechnology · GuangzhouSeries Unknown
Ruixun Biotech
December 2024

Ruixun Biotech is a healthcare company that provides biotechnology.

Biotechnology · SuzhouSeries C
Farber Xintian
December 2024

Farber Xintian CRO company engaged in clinical services of radionuclide drugs.

Medical$13.8M Series A
Valora Therapeutics
November 2024

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

Biopharma · La Jolla$30.0M Seed
MacroLux
October 2024

MacroLux operates as a medical technology company focusing on endoscopic interventional business.

Health Care · Shenzhen$14.0M Series B
IntoCare
October 2024

IntoCare is a high-tech company specializing in surgical products.

Health Care · Suzhou$10.0M Series D
Pro-Heal Pharmaceuticals
June 2024

Pro-Heal Pharmaceuticals is a biotechnology based pharmaceutical manufacturing company.

Biopharma · Suzhou$5.5M Corporate Round
āshibio
June 2024

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

Biotechnology · Brisbane$40.0M Series A
Simergent
May 2024

Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.

Emerging Markets · Chicago$7.8M Series Unknown
Youzhong New Material Technology
April 2024

Youzhong New Materials is a micro-nano device R&D company that designs, develops, and manufactures micro-nano devices .

Manufacturing · Zhoushan$13.8M Series A
Bask Health
April 2024

SaaS, Healthcare, E-commerce

Electronic Health Record (EHR) · New York$760K Seed
Jushu Biotech
April 2024

Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology.

Biopharma · ChangpingSeries A
Baikuirui
April 2024

Baikuirui is an antibiotic resistance biosynthesis developing company.

Biotechnology · Shenzhen$1.4M Series A
Rallybio
April 2024

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Biopharma · Farmington$6.6M Post Ipo Equity
Neurosterix
April 2024

Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

Biopharma · Geneva$65.0M Series A
Brattea
March 2024

Brattea is a medical device research and development company.

Health Care · ShanghaiSeries D
varnotech
March 2024

Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.

Intellectual Property · Beijing$83.0M Series B

Where BioVenture invests

Medical12
Biotechnology11
Health Care11
Biopharma6
Therapeutics5
Manufacturing4

About BioVenture's portfolio

How many companies has BioVenture invested in?

BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?

BioVenture's top investment sectors include Medical, Biotechnology, Health Care, Biopharma, Therapeutics. The firm invests across 26 different industry categories.

What is BioVenture's largest investment?

Among tracked funding rounds, varnotech received $83.0M in a Series B round. BioVenture's total known invested capital is $1.0B.

What is the average investment size for BioVenture?

BioVenture's average investment size is $20.1M across its portfolio of 274 companies.

What are BioVenture's most recent investments?

Recent BioVenture portfolio additions include Apeximmune Therapeutics, Cellbri, Myrobalan Therapeutics, MyoGene Life Sciences, AnaCardio. These companies were founded in 2020 or later.

Reach the founders behind these 274 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →